NDC product
Ambien
NDC 0024-5401 · Sanofi-Aventis U.S. LLC
Key facts
| Product NDC | 0024-5401 |
|---|---|
| Proprietary name | Ambien |
| Nonproprietary name | zolpidem tartrate |
| Substances | ZOLPIDEM TARTRATE |
| Dosage form | TABLET, FILM COATED |
| Route | ORAL |
| Labeler | Sanofi-Aventis U.S. LLC |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Application number | NDA019908 |
| DEA schedule | CIV |
| Pharmacologic classes | Central Nervous System Depression [PE], GABA A Receptor Positive Modulators [MoA], gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC] |
| Marketing start | Apr 1, 1993 |
| Marketing end | Oct 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory